|
ZNF250 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.05120000000326E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.169470E-04 |
| Normal-vs-Stage2 |
2.579800E-01 |
| Normal-vs-Stage3 |
1.75670000002182E-06 |
| Normal-vs-Stage4 |
2.05759999999389E-05 |
| Stage1-vs-Stage2 |
2.231800E-02 |
| Stage1-vs-Stage3 |
1.781590E-01 |
| Stage1-vs-Stage4 |
2.016600E-01 |
| Stage2-vs-Stage3 |
1.995210E-03 |
| Stage2-vs-Stage4 |
4.240300E-03 |
| Stage3-vs-Stage4 |
8.428600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.02059999999871E-05 |
| Normal-vs-AfricanAmerican |
5.600200E-02 |
| Normal-vs-Asian |
1.519040E-03 |
| Caucasian-vs-AfricanAmerican |
4.682400E-01 |
| Caucasian-vs-Asian |
4.238000E-01 |
| AfricanAmerican-vs-Asian |
7.900800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.424100E-04 |
| Normal-vs-Female |
5.81179999999959E-05 |
| Male-vs-Female |
3.985400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.601100E-04 |
| Normal-vs-Age(41-60Yrs) |
6.14289999999462E-05 |
| Normal-vs-Age(61-80Yrs) |
9.834200E-04 |
| Normal-vs-Age(81-100Yrs) |
3.266200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.010400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.091000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.353800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.352600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.836000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.643400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.162000E-02 |
| Classical-VS-Follicular |
6.333400E-01 |
| Classical-VS-Other |
5.317400E-01 |
| Classical-VS-Normal |
3.035000E-04 |
| Tall-VS-Follicular |
8.902500E-03 |
| Tall-VS-Other |
5.033600E-02 |
| Tall-VS-Normal |
8.32729999955539E-07 |
| Follicular-VS-Other |
7.549200E-01 |
| Follicular-VS-Normal |
5.163300E-03 |
| Other-VS-Normal |
3.101200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.66600000000217E-05 |
| Normal-vs-N1 |
2.20499999999957E-05 |
| N0-vs-N1 |
2.216000E-01 |
|
|
